Top

Current Atherosclerosis Reports

Content (5 Articles)

Open Access Hypercholesterolemia Statin Drugs (M. Tikkanen, Section Editor)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients

Timo E. Strandberg

Dapagliflozin Emerging Research (S. Virani, Section Editor)

Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session

Mahmoud Al Rifai, Xiaoming Jia, Mouaz H. Al-Mallah, Michael D. Miedema, Seth S. Martin, Salim S. Virani

Stroke Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor)

Anticoagulation Resumption After Stroke from Atrial Fibrillation

Brian Mac Grory, Shane Flood, Matthew Schrag, Maurizio Paciaroni, Shadi Yaghi

Open Access Lipolysis Nonstatin Drugs (R. Carmena, Section Editor)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

Marja-Riitta Taskinen, Chris J. Packard, Jan Borén

PCSK9 Inhibitor Nonstatin Drugs (R. Carmena, Section Editor)

Antisense Oligonucleotides Targeting Lipoprotein(a)

Anne Langsted, Børge G. Nordestgaard

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.